Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
Condition | Onset Date | Status |
---|---|---|
Ischemic heart disease | 1999-07-07 | active |
Polyp of colon | 1998-11-16 | active |
Metabolic syndrome X | 1990-04-25 | active |
Prediabetes | 1989-05-03 | active |
Anemia | 1989-05-03 | active |
Essential hypertension | 1973-01-31 | active |
Medication | Since | Form | Dosage | Reason |
---|---|---|---|---|
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2024-11-27 | Oral tablet | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
Lisinopril 10 mg oral tablet | 2024-11-27 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 1999-07-14 | Oral tablet | 1 tablet (75 mg) once daily | |
Simvastatin 20 mg oral tablet | 1999-07-14 | Oral tablet | 1 tablet (20 mg) once daily | |
Nitroglycerin 400 microgram/actuation sublingual spray | 1999-07-14 | Sublingual spray | 400 micrograms per spray, use 1 spray under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | |
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 1999-07-14 | Prolonged-release oral tablet | 1 tablet (100 mg) once daily |
No known allergies or intolerances |
Procedure | Date | Reason |
---|---|---|
Patient discharge | 2024-01-01 | - |
Hospice care | 2023-12-31 | - |
Notifications | 2023-11-29 | - |
Certification procedure | 2023-11-29 | - |
Initial patient assessment | 2023-11-29 | - |
Development of individualized plan of care | 2023-11-29 | - |
Vaccine | Date |
---|---|
Influenza virus antigen only vaccine product | 2024-11-27 |
SARS-CoV-2 mRNA vaccine | 2021-02-24 |
Clostridium tetani toxoid antigen adsorbed only vaccine product | 2020-11-04 |
Immunization Recommendation | Due Date | Reason |
---|---|---|
Vaccine product containing only Influenza virus antigen (medicinal product) | 2025-10-01 | Annual seasonal influenza vaccination |
Condition | Period | Status |
---|---|---|
Acute bronchitis | 2021-02-06 – 2021-02-17 | inactive |
Viral sinusitis | 2016-04-13 – 2016-05-09 | inactive |
Vital Signs | 2024-11-27 | 2023-11-22 |
---|---|---|
Body Height | 175.6 cm | 175.6 cm |
Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 {score} | 3 {score} |
Body Weight | 89.3 kg | 87.5 kg |
Body mass index (BMI) [Ratio] | 29 kg/m2 | 28.4 kg/m2 |
Diastolic Blood Pressure | 103 mm[Hg] | 91 mm[Hg] |
Systolic Blood Pressure | 122 mm[Hg] | 117 mm[Hg] |
Heart rate | 79 /min | 81 /min |
Respiratory rate | 13 /min | 16 /min |